Patents Assigned to Oncoinvent AS
  • Monoclonal antibody and derivatives
    Patent number: 9782500
    Abstract: The present invention relates to a novel anti-CD146 antibody and derivatives thereof. The antibody and/or derivatives can be used for therapy and/or imaging, diagnosis and/or immunostaining.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: October 10, 2017
    Assignee: Oncoinvent AS
    Inventors: Tina Bjørnlund Bønsdorff, Roy Hartvig Larsen
  • Radiotherapeutic particles and suspensions
    Patent number: 9539346
    Abstract: The present invention relates to a particle or pharmaceutical composition comprising one, more particles or a suspension of same or different particles comprising a degradable compound and an alpha emitting radionuclide and/or a radionuclide generating alpha emitting daughter. The particles are beneficial for use in the treatment of cancer.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: January 10, 2017
    Assignee: Oncoinvent AS
    Inventors: Roy Hartvig Larsen, Sara Westrøm